​
​

Rhythm Pharmaceuticals Ownership | Who Owns Rhythm Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Rhythm Pharmaceuticals Ownership Summary

Rhythm Pharmaceuticals is owned by 115.23% institutional investors, 0.54% insiders. Primecap management co/ca/ is the largest institutional shareholder, holding 12.16% of RYTM shares. PRIMECAP Odyssey Aggressive Growth is the top mutual fund, with 7.84% of its assets in Rhythm Pharmaceuticals shares.

RYTM Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRhythm Pharmaceuticals115.23%0.54%-15.77%
SectorHealthcare Stocks 47.38%7.99%44.63%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Primecap management co/ca/7.31M12.16%$300.25M
Blackrock6.74M11.21%$276.82M
Baker bros. advisors lp6.40M10.64%$262.72M
Ra capital management6.08M10.12%$249.83M
Goldman sachs group5.29M8.79%$217.15M
Perceptive advisors3.45M5.73%$141.52M
Vanguard group3.36M5.59%$137.99M
Nea management company2.91M4.84%$119.48M
Frazier life sciences management2.37M3.94%$97.37M
State street2.00M3.33%$82.28M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Checkpoint capital922.10K22.82%$37.86M
Nea management company2.91M8.99%$119.48M
Opaleye management515.00K4.83%$21.15M
Frazier life sciences management2.37M4.55%$97.37M
Commodore capital lp1.23M3.43%$50.30M
Perceptive advisors3.45M3.36%$141.52M
Baker bros. advisors lp6.40M3.36%$262.72M
Ra capital management6.08M3.30%$249.83M
Nan fung group49.12K2.15%$2.02M
Silverarc capital management184.66K1.79%$7.58M

Top Buyers

HolderShares% AssetsChange
Alkeon capital management1.00M0.07%1.00M
Ra capital management6.08M3.30%754.00K
Driehaus capital management1.18M0.47%326.87K
Morgan stanley475.65K0.00%292.78K
Candriam s.c.a.271.40K0.07%271.40K

Top Sellers

HolderShares% AssetsChange
State street2.00M0.00%-1.01M
Primecap management co/ca/7.31M0.22%-435.20K
Pictet asset management sa801.80K0.04%-409.88K
Artisan partners limited partnership---271.27K
Rock springs capital management lp1.28M1.58%-242.40K

New Positions

HolderShares% AssetsChangeValue
Alkeon capital management1.00M0.07%1.00M$41.06M
Candriam s.c.a.271.40K0.07%271.40K$11.14M
Nomura157.30K0.01%157.30K$6.46M
Abrdn112.80K0.01%112.80K$4.63M
Hap trading109.80K0.04%109.80K$312.93K

Sold Out

HolderChange
Innealta capital-7.00
Nelson, van denburg & campbell wealth management group-10.00
Mather group, llc.-65.00
Truvestments capital-216.00
Pacer advisors-413.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024174-1.14%69,303,0851.97%1150.90%902.27%52-5.45%
Mar 31, 2024176-0.56%67,967,4711.91%1130.84%882.33%55-15.38%
Dec 31, 202317715.69%66,693,635-2.13%1150.83%86-4.44%6571.05%
Sep 30, 202315327.50%68,148,1052.73%1170.87%9026.76%3865.22%
Jun 30, 2023120-10.45%66,334,9419.94%1161.03%71-5.33%23-8.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
PRIMECAP Odyssey Aggressive Growth4.79M7.84%-53.70K
PRIMECAP Odyssey Growth2.09M3.42%-32.23K
Vanguard Total Stock Mkt Idx Inv1.92M3.14%2.33K
Polar Capital Biotech S Inc1.50M2.45%-
iShares Russell 2000 ETF1.41M2.29%-3.16K
Federated Hermes Kaufmann R840.00K1.37%-
Federated Hermes Kaufmann Growth840.00K1.37%-
Federated Hermes Kaufmann Small Cap Grow800.00K1.31%-
Federated Hermes Kaufmann Small Cap A800.00K1.31%-
Vanguard Institutional Extnd Mkt Idx Tr790.14K1.29%4.71K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 11, 2024Lee Jennifer Kayden EVP, Head of North AmericaSell$13.69K
Nov 11, 2024Lee Jennifer Kayden EVP, Head of North AmericaSell$2.50M
Nov 11, 2024Lee Jennifer Kayden EVP, Head of North AmericaSell$1.17M
Nov 11, 2024Lee Jennifer Kayden EVP, Head of North AmericaSell$747.87K
Nov 11, 2024Shulman Joseph Chief Technical OfficerSell$434.07K

Insider Transactions Trends

DateBuySell
2024 Q4-9
2024 Q3-17
2024 Q2-3
2024 Q1-29
2023 Q4-13

RYTM Ownership FAQ

Who Owns Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals shareholders are primarily institutional investors at 115.23%, followed by 0.54% insiders and -15.77% retail investors. The average institutional ownership in Rhythm Pharmaceuticals's industry, Biotech Stocks , is 45.43%, which Rhythm Pharmaceuticals exceeds.

Who owns the most shares of Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals’s largest shareholders are Primecap management co/ca/ (7.31M shares, 12.16%), Blackrock (6.74M shares, 11.21%), and Baker bros. advisors lp (6.4M shares, 10.64%). Together, they hold 34.01% of Rhythm Pharmaceuticals’s total shares outstanding.

Does Blackrock own Rhythm Pharmaceuticals?

Yes, BlackRock owns 11.21% of Rhythm Pharmaceuticals, totaling 6.74M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 276.82M$. In the last quarter, BlackRock increased its holdings by 212.28K shares, a 3.25% change.

Who is Rhythm Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Checkpoint capital is Rhythm Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 22.82% of its assets in 922.1K Rhythm Pharmaceuticals shares, valued at 37.86M$.

Who is the top mutual fund holder of Rhythm Pharmaceuticals shares?

PRIMECAP Odyssey Aggressive Growth is the top mutual fund holder of Rhythm Pharmaceuticals shares, with 7.84% of its total shares outstanding invested in 4.79M Rhythm Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools